Orly Mishan Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity
Orly Mishan is Chief Business Officer of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 38,450 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Jan 26, 2021, when has been sold 38,450 shares (Common Stock) at a price of $3.5 per share, resulting in proceeds of $134,575. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
38.5K
0%
3M change
0%
12M change
Total Value Held
$0
OM
Orly Mishan
Chief Business Officer
Cambridge, MA